Rash, neutrophil-lymphocyte ratio (NLR) and survival in the REAL3 trial
Authors
Smyth, EKouvelakis, K
Peckitt, C
Waddell, Thomas
Watkins, D
Rao, S
Starling, N
Saffery, C
Okines, A
Chau, I
Cunningham, D
Affiliation
Gastrointestinal Oncology, Royal Marsden Hospital NHS Foundation Trust, LondonIssue Date
2017-11
Metadata
Show full item recordCitation
Rash, neutrophil-lymphocyte ratio (NLR) and survival in the REAL3 trial 2017, 28 (suppl_10) Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdx660.011Type
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx660.011